Human Vaccines & Immunotherapeutics (Nov 2022)

First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world

  • Jinmiao Lu,
  • Xunjie Zhang,
  • Hong Xu,
  • Zhiping Li

DOI
https://doi.org/10.1080/21645515.2022.2080443
Journal volume & issue
Vol. 18, no. 5

Abstract

Read online

The Bacillus Calmette-Guérin (BCG) vaccine is a free vaccine in China, and more than 300 million newborns have been vaccinated. Inevitably, the BCG vaccine will have some rare adverse events on the first day of life (24 hours after birth), but related reports are extremely rare. In this commentary, the authors searched the Chinese legal documents database for documents related to serious adverse events caused by BCG from January 2010 to January 2022. Fourteen pediatric cases were identified, including 7 preterm infants and 7 full-term infants. The events included 4 cases of interstitial pneumonia, 3 cases of lymphadenitis, 3 cases of septicemia, 1 case of myocarditis, 1 case of muscle atrophy, 1 case of epilepsy, and 1 case of disseminated BCG vaccine. The mortality rate of preterm infants was 100% and that of full-term infants was 28.6% (2/7). All deaths occurred within one day. The BCG vaccine has good safety for the vast majority of newborns.

Keywords